Schedule 13D ownership disclosure
CALLIDITAS THERAPEUTICS AB
Security class unavailable · CUSIP: 13124Q106
Event date: 2024-05-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 29,331,211
- Percent of class
- 54.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-24-049741
- Form type
- SC 13D
- Filer
- Asahi Kasei Corp
- CIK
- CIK 1446531
- Filed
- Jun 04, 2024
- Reporting period
- May 27, 2024
- Description
- Schedule 13D beneficial ownership